These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10452868)

  • 1. Products of cyclooxygenase-2 catalysis regulate postoperative bowel motility.
    Josephs MD; Cheng G; Ksontini R; Moldawer LL; Hocking MP
    J Surg Res; 1999 Sep; 86(1):50-4. PubMed ID: 10452868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
    Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
    Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.
    Bouras EP; Burton DD; Camilleri M; Stephens DA; Thomforde GM
    Neurogastroenterol Motil; 2004 Dec; 16(6):729-35. PubMed ID: 15601422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salsalate, morphine, and postoperative ileus.
    Cheng G; Cassissi C; Drexler PG; Vogel SB; Sninsky CA; Hocking MP
    Am J Surg; 1996 Jan; 171(1):85-8; discussion 88-9. PubMed ID: 8554157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric and small bowel ileus after severe burn in rats: the effect of cyclooxygenase-2 inhibitors.
    Oliveira HM; Sallam HS; Espana-Tenorio J; Chinkes D; Chung DH; Chen JD; Herndon DN
    Burns; 2009 Dec; 35(8):1180-4. PubMed ID: 19464805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
    Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M
    Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
    Ohno R; Yokota A; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
    Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
    Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse.
    Menozzi A; Pozzoli C; Poli E; Dacasto M; Giantin M; Lopparelli RM; Passeri B; Zullian C; Gobbetti T; Bertini S
    Res Vet Sci; 2009 Feb; 86(1):129-35. PubMed ID: 18565556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
    Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
    Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress.
    Bugajski J; Gadek-Michalska A; Bugajski AJ
    J Physiol Pharmacol; 2002 Sep; 53(3):453-62. PubMed ID: 12369741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
    Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
    J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.